A2B adenosine receptor antagonists

Details for Australian Patent Application No. 2004285013 (hide)

Owner CV Therapeutics, Inc.

Inventors Elzein, Elfatih; Li, Xiaofen; Kalla, Rao; Marquart, Tim; Zablocki, Jeff; Perry, Thao

Agent Freehills

Pub. Number AU-A-2004285013

PCT Pub. Number WO2005/042534

Priority 60/516,019 31.10.03 US

Filing date 26 October 2004

Wipo publication date 12 May 2005

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/042534 Priority application(s): WO2005/042534

16 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004285017-Ink jet printer that prints using chromatic inks of multiple types

2004284997-Diamine derivative, process for producing the same, and plant disease control agent containing the same as active ingredient